Otros idiomas QuantRx Biomedical Corporation

Acciones

QTXB

US74765N1090

Mercado cerrado - OTC Markets Otros sitios de cotización 19:37:42 26/02/2024			Varia. Cinco días.	Varia. 1 de enero.
0,004 ^USD	-.--%		-.--%	-49,37 %

2022	QuantRx Biomedical Corporation informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2022	CI
2022	Michael Abrams dimite como miembro del Consejo de Administración de QuantRx Biomedical Corporation	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
QuantRx Biomedical : Management Change/Compensation - Form 8-K	24/08/22
Michael Abrams Resigns as a Member of the Board of Directors of QuantRx Biomedical Corporation	24/08/22
QUANTRX BIOMEDICAL CORP : Change in Directors or Principal Officers (form 8-K)	24/08/22
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/08/22
QuantRx Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22/08/22
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/05/22
QuantRx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
QUANTRX BIOMEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/04/22
QuantRx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22
QuantRx Biomedical Corporation Auditor Raises 'Going Concern' Doubt	15/04/22
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/11/21
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/11/21
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/08/21
Quantrx Biomedical Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	17/05/21
Quantrx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	17/05/21
QUANTRX BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/04/21
Quantrx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	15/04/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas QuantRx Biomedical Corporation

Acciones

QTXB

US74765N1090

Otros idiomas

Filtros